alemtuzumab

Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science
Endpoints
Thu, 05/13/21 - 11:59 pm
Sanofi
Cellectis
allogeneic cells
CAR-T
alemtuzumab
Lemtrada
Alemtuzumab (Lemtrada) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study
Yahoo/BusinessWire
Sat, 10/22/11 - 12:30 pm
alemtuzumab
Lemtrada
Sanofi
Genzyme
multiple sclerosis
Phase III Data Mixed on Sanofi's Lemtrada
Yahoo/Zacks.com
Wed, 07/13/11 - 06:25 pm
Sanofi
Lemtrada
MS
multiple sclerosis
alemtuzumab
Genzyme advances key drug in Sanofi deal
Bizjournals.com
Thu, 04/14/11 - 06:23 pm
Genzyme
Sanofi
MS
multiple sclerosis
alemtuzumab
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Sat, 11/27/10 - 12:53 pm
Genzyme
alemtuzumab
Sanofi
MS
multiple sclerosis
Genzyme's MS Drug Shows Promise
Seeking Alpha
Fri, 09/18/09 - 11:21 am
Genzyme
multiple sclerosis
MS
alemtuzumab